A detailed history of Bay Colony Advisory Group, Inc D transactions in Eli Lilly & CO stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 4,366 shares of LLY stock, worth $3.48 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
4,366
Previous 5,427 19.55%
Holding current value
$3.48 Million
Previous $4.91 Million 21.27%
% of portfolio
0.61%
Previous 0.85%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $819,240 - $1.02 Million
-1,061 Reduced 19.55%
4,366 $3.87 Million
Q2 2024

Jul 24, 2024

SELL
$724.87 - $909.04 $385,630 - $483,609
-532 Reduced 8.93%
5,427 $4.91 Million
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $785,849 - $1.05 Million
-1,327 Reduced 18.21%
5,959 $4.64 Million
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $983,155 - $1.16 Million
1,872 Added 34.58%
7,286 $4.25 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $149,102 - $205,559
-343 Reduced 5.96%
5,414 $2.91 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $49,103 - $65,657
-140 Reduced 2.37%
5,757 $2.7 Million
Q1 2023

Apr 27, 2023

SELL
$310.63 - $364.82 $31,994 - $37,576
-103 Reduced 1.72%
5,897 $2.03 Million
Q4 2022

Feb 01, 2023

SELL
$321.55 - $374.67 $114,471 - $133,382
-356 Reduced 5.6%
6,000 $2.2 Million
Q3 2022

Oct 27, 2022

BUY
$296.48 - $337.87 $62,557 - $71,290
211 Added 3.43%
6,356 $2.06 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $90,029 - $105,708
-323 Reduced 4.99%
6,145 $2.03 Million
Q1 2022

Apr 28, 2022

BUY
$234.69 - $291.66 $100,916 - $125,413
430 Added 7.12%
6,468 $1.85 Million
Q4 2021

Jan 28, 2022

BUY
$224.85 - $279.04 $134,235 - $166,586
597 Added 10.97%
6,038 $1.67 Million
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $32,575 - $40,088
-147 Reduced 2.63%
5,441 $1.26 Million
Q2 2021

Jul 22, 2021

BUY
$180.55 - $233.54 $236,701 - $306,170
1,311 Added 30.65%
5,588 $1.28 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $21,197 - $27,440
129 Added 3.11%
4,277 $799,000
Q4 2020

Feb 02, 2021

BUY
$130.46 - $172.63 $80,102 - $105,994
614 Added 17.37%
4,148 $700,000
Q3 2020

Nov 25, 2020

BUY
$146.22 - $169.13 $133,060 - $153,908
910 Added 34.68%
3,534 $523,000
Q2 2020

Jul 23, 2020

BUY
$136.42 - $164.18 $954 - $1,149
7 Added 0.27%
2,624 $431,000
Q1 2020

Apr 17, 2020

BUY
$119.05 - $147.35 $100,954 - $124,952
848 Added 47.94%
2,617 $363,000
Q4 2019

Jan 28, 2020

BUY
$106.92 - $132.43 $189,141 - $234,268
1,769 New
1,769 $250,000
Q3 2018

Nov 05, 2018

SELL
$85.86 - $107.31 $114,708 - $143,366
-1,336 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$75.7 - $86.88 $101,135 - $116,071
1,336 New
1,336 $114,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.